Borderline tuberculoid leprosy
- A30.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM A30.2 became effective on October 1, 2023.
- This is the American ICD-10-CM version of A30.2 – other international versions of ICD-10 A30.2 may differ.
Applicable To
- BT leprosy
The following code(s) above A30.2 contain annotation back-references
that may be applicable to A30.2:
ICD-10-CM A30.2 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 867 Other infectious and parasitic diseases diagnoses with mcc
- 868 Other infectious and parasitic diseases diagnoses with cc
- 869 Other infectious and parasitic diseases diagnoses without cc/mcc
Convert A30.2 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Diagnosis Index entries containing back-references to A30.2:
- Leprosy
- borderline (infiltrated) (neuritic) A30.3
- tuberculoid A30.2
- BT A30.2
- borderline (infiltrated) (neuritic) A30.3